OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding access to CAR T cell therapies through local manufacturing
Magdi Elsallab, Marcela V. Maus
Nature Biotechnology (2023) Vol. 41, Iss. 12, pp. 1698-1708
Closed Access | Times Cited: 30
Magdi Elsallab, Marcela V. Maus
Nature Biotechnology (2023) Vol. 41, Iss. 12, pp. 1698-1708
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 73
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 73
A roadmap for affordable genetic medicines
Melinda Kliegman, Manar Zaghlula, Susan L. Abrahamson, et al.
Nature (2024) Vol. 634, Iss. 8033, pp. 307-314
Closed Access | Times Cited: 20
Melinda Kliegman, Manar Zaghlula, Susan L. Abrahamson, et al.
Nature (2024) Vol. 634, Iss. 8033, pp. 307-314
Closed Access | Times Cited: 20
A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells
Wei‐Xiang Sin, N. Suhas Jagannathan, Denise Bei Lin Teo, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 10
Wei‐Xiang Sin, N. Suhas Jagannathan, Denise Bei Lin Teo, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 10
Enhancing pediatric access to cell and gene therapies
Crystal L. Mackall, Catherine M. Bollard, Nancy L. Goodman, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1836-1846
Closed Access | Times Cited: 10
Crystal L. Mackall, Catherine M. Bollard, Nancy L. Goodman, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1836-1846
Closed Access | Times Cited: 10
Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies
Zongjie Wang, Shana O. Kelley
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Zongjie Wang, Shana O. Kelley
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Engineering CAR-T therapies for autoimmune disease and beyond
Emily P. English, Robert Swingler, Simran Patwa, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 771
Open Access | Times Cited: 6
Emily P. English, Robert Swingler, Simran Patwa, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 771
Open Access | Times Cited: 6
Boarding pyroptosis onto nanotechnology for cancer therapy
Weiyue Ban, Zhichao Chen, Tao Zhang, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 653-676
Closed Access | Times Cited: 4
Weiyue Ban, Zhichao Chen, Tao Zhang, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 653-676
Closed Access | Times Cited: 4
Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India
Kirthiga Devi S S, Ramesh Joga, Saurabh Srivastava, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114361-114361
Open Access | Times Cited: 4
Kirthiga Devi S S, Ramesh Joga, Saurabh Srivastava, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114361-114361
Open Access | Times Cited: 4
Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy
Gabriel Gallo-Oller, María Isabel Guillén-Antonini, Javier Dotor
International review of cell and molecular biology (2025)
Closed Access
Gabriel Gallo-Oller, María Isabel Guillén-Antonini, Javier Dotor
International review of cell and molecular biology (2025)
Closed Access
Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer
Zibai Lyu, Shaoqiang Niu, Ying Fang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Zibai Lyu, Shaoqiang Niu, Ying Fang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Chimeric antigen receptor T cell therapy in childhood leukaemia
Stacie Shiqi Wang, Rebecca C Abbott, Maddie Gilsenan, et al.
Archives of Disease in Childhood (2025), pp. archdischild-328263
Closed Access
Stacie Shiqi Wang, Rebecca C Abbott, Maddie Gilsenan, et al.
Archives of Disease in Childhood (2025), pp. archdischild-328263
Closed Access
Establishing a GMP-compliant manufacturing process and phase-appropriate analytics for early development of a FiCAR T-cell product with a novel CAR spacer
Annu Luostarinen, Arto Vuorela, Erja Kerkelä, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Annu Luostarinen, Arto Vuorela, Erja Kerkelä, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
CGT 4.0: a distant dream or inevitable future? Smart process automation is critical to make efficient scalability of CGT manufacturing a reality
Aleksander Szarzynski, Oliver Spadiut, Matthias Reisbeck, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Aleksander Szarzynski, Oliver Spadiut, Matthias Reisbeck, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Designing next‐generation immune cell therapies with nanomaterials
Kangfu Chen, Wenhan Wang, Zongjie Wang
BMEMat (2025)
Open Access
Kangfu Chen, Wenhan Wang, Zongjie Wang
BMEMat (2025)
Open Access
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D.J. Pearson, Claudia Rössig, Crystal L. Mackall, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 4, pp. e214-e224
Closed Access
Andrew D.J. Pearson, Claudia Rössig, Crystal L. Mackall, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 4, pp. e214-e224
Closed Access
Surveying local CAR T-cell manufacturing processes to facilitate standardization and expand accessibility
Dolly Gupta, Beth H. Shaz
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Dolly Gupta, Beth H. Shaz
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells
Magdi Elsallab, Florence T. Bourgeois, Marcela V. Maus
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 6, pp. 626.e1-626.e11
Closed Access | Times Cited: 3
Magdi Elsallab, Florence T. Bourgeois, Marcela V. Maus
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 6, pp. 626.e1-626.e11
Closed Access | Times Cited: 3
Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturing
Mona T. Elsemary, Michelle F. Maritz, Louise E. Smith, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1264-1274
Open Access | Times Cited: 3
Mona T. Elsemary, Michelle F. Maritz, Louise E. Smith, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1264-1274
Open Access | Times Cited: 3
The current socioeconomic and regulatory landscape of immune effector cell therapies
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Advances in manufacturing chimeric antigen receptor immune cell therapies
Apoorva Ramamurthy, Anna Tommasi, Krishanu Saha
Seminars in Immunopathology (2024) Vol. 46, Iss. 5
Closed Access | Times Cited: 2
Apoorva Ramamurthy, Anna Tommasi, Krishanu Saha
Seminars in Immunopathology (2024) Vol. 46, Iss. 5
Closed Access | Times Cited: 2
Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10365-10365
Open Access | Times Cited: 2
Lorenzo Giorgioni, Alessandra Ambrosone, Maria Francesca Cometa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10365-10365
Open Access | Times Cited: 2
In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy
Jin Qu, Yuan Wang, Chuxiao Xiong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jin Qu, Yuan Wang, Chuxiao Xiong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)–T-Cell therapy
Robert Hoyt, Zhan Ye, Amitava Dasgupta
Clinica Chimica Acta (2024) Vol. 559, pp. 119704-119704
Open Access | Times Cited: 1
Robert Hoyt, Zhan Ye, Amitava Dasgupta
Clinica Chimica Acta (2024) Vol. 559, pp. 119704-119704
Open Access | Times Cited: 1
Nanotechnology‐Assisted CAR ‐T‐Cell Therapy for Tumor Treatment
Yixin Wang, Allie Barrett, Quanyin Hu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 1
Yixin Wang, Allie Barrett, Quanyin Hu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 5
Closed Access | Times Cited: 1
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage
Guilherme Meira Lima, Zeinab Jame-Chenarboo, Mirat Sojitra, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 1
Guilherme Meira Lima, Zeinab Jame-Chenarboo, Mirat Sojitra, et al.
Cell chemical biology (2024)
Closed Access | Times Cited: 1
